Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
about
Telomeres and telomere dynamics: relevance to cancers of the GI tractAnal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapyMetastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm?The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canalPrognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy.Review of the molecular profile and modern prognostic markers for gastric lymphoma: how do they affect clinical practice?High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal CanalSignificance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.Survival rate variation with different histological subtypes of poor prognostic male anal squamous cell carcinoma: a population-based study.Background and Current Treatment of Squamous Cell Carcinoma of the Anus.Loss of Raf kinase inhibitor protein expression is associated with human papillomavirus 16 infection in anal tumors.
P2860
Q28394311-27775CB4-B1EB-41B7-952C-7883B829FB95Q30409533-0B856A06-B5CA-456C-B4F4-154B9CD5FC1FQ30415832-85F9796A-FF1B-4456-95A3-AAE5FFE844A0Q33885578-51A47440-35CF-4B02-8FFD-C5670ABE370DQ34276791-97C38A6D-1856-48AA-A897-2AEAFEE2BFFCQ34278279-669E9609-9EDE-417B-B049-BD885422481EQ34433781-2BA42AC3-FC9F-4EC8-9851-22852EEC648DQ34957320-4F18A94A-48F4-4E15-8B39-6CE21FD11870Q35750692-8448B94E-6E6E-45F3-9CBC-2BF80264300DQ35847885-26563FD5-BD9B-4DAF-9199-6F5CD363C8A6Q36198307-2F2BA262-447C-41F4-8AE3-6775EB6DB709Q36478774-37B82741-831A-4E9C-923A-B655D0416A52Q38996898-77155882-6D8A-4B34-B43B-A89937B5EC12Q44990570-16A1D9FC-9DF0-41D2-BFE4-E3C22D86EC0BQ50897271-90C2B7EF-B97B-4F0B-AE7B-4AB1E64113C4Q55690226-FD3DBC51-E8EB-4068-842F-B02E86BE6FA5
P2860
Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Molecular biomarkers correlate ...... a treated with chemoradiation.
@en
Molecular biomarkers correlate ...... a treated with chemoradiation.
@nl
type
label
Molecular biomarkers correlate ...... a treated with chemoradiation.
@en
Molecular biomarkers correlate ...... a treated with chemoradiation.
@nl
prefLabel
Molecular biomarkers correlate ...... a treated with chemoradiation.
@en
Molecular biomarkers correlate ...... a treated with chemoradiation.
@nl
P2093
P1476
Molecular biomarkers correlate ...... a treated with chemoradiation.
@en
P2093
Asif Rashid
Christopher H Crane
Jaffer A Ajani
John M Skibber
Julie G Izzo
Prajnan Das
Xuemei Wang
P2860
P2888
P304
P356
10.1007/S10620-009-0812-6
P577
2009-04-28T00:00:00Z